Dyslipidemia, characterized by a high level of lipids (cholesterol, triglycerides, or both), can
increase the risk of developing and progressing atherosclerosis. As atherosclerosis …

Sugar-based polymers have been extensively explored as a means to increase drug
delivery systems' biocompatibility and biodegradation. Here, we review the use of sugar …

Advances in nanoformulation have driven progress in biomedicine by producing nanoscale
tools for biosensing, imaging, and drug delivery. Flash-based technology, the combination of …

Atherosclerosis, the build-up of occlusive, lipid-rich plaques in arterial walls, is a focal trigger
of chronic coronary, intracranial, and peripheral arterial diseases, which together account for …

Atherosclerosis, driven by chronic inflammation of the arteries and lipid accumulation on the
blood vessel wall, underpins many cardiovascular diseases with high mortality rates …

Atherosclerosis is a major cause of sudden death and myocardial infarction, instigated by
unstable plaques. Thus, the early detection of unstable plaques and corresponding …

Native nanostructured lipoproteins such as low-and high-density lipoproteins (LDL and
HDL) are powerful tools for the targeted delivery of drugs and imaging agents. While the …

Atherosclerosis is the leading cause of death in developed countries. The pathogenetic
mechanism relies on a macrophage-based immune reaction to low density lipoprotein (LDL) …

Vascular‐targeted nanocarriers are an attractive option for the treatment of a number of
cardiovascular diseases, as they allow for more specific delivery and increased efficacy of …

Atherosclerosis is Caesar's sword, which poses a huge risk to the present generation.
Understanding the atherosclerotic disease cycle would allow ensuring improved diagnosis …